Matches in Wikidata for { <http://www.wikidata.org/entity/Q65537574> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q65537574 description "clinical trial" @default.
- Q65537574 description "ensayu clínicu" @default.
- Q65537574 description "klinisch onderzoek" @default.
- Q65537574 description "клінічне випробування" @default.
- Q65537574 name "A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)" @default.
- Q65537574 name "A Study of the Safety and Efficacy of Golimumab" @default.
- Q65537574 type Item @default.
- Q65537574 label "A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)" @default.
- Q65537574 label "A Study of the Safety and Efficacy of Golimumab" @default.
- Q65537574 prefLabel "A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)" @default.
- Q65537574 prefLabel "A Study of the Safety and Efficacy of Golimumab" @default.
- Q65537574 P1050 Q65537574-29FFED20-B6B9-4242-B4EF-3C1C9B203533 @default.
- Q65537574 P1132 Q65537574-03178952-EAB4-4AF0-8ED3-05A2AE723952 @default.
- Q65537574 P1476 Q65537574-8C392279-50EF-4586-B6D8-1E32CAF00B10 @default.
- Q65537574 P17 Q65537574-08173E4D-54F8-4854-A335-A3ABFAF9C347 @default.
- Q65537574 P17 Q65537574-251EACCC-A7BE-4276-B817-710E906F6A40 @default.
- Q65537574 P17 Q65537574-39E0EFE2-392D-4837-9F93-B0F74F5F78FE @default.
- Q65537574 P17 Q65537574-6DFB17EC-60C7-4D68-9946-7C3990A50D42 @default.
- Q65537574 P17 Q65537574-6FBD5C8B-8FBB-4DB5-9B76-7502A68024A6 @default.
- Q65537574 P17 Q65537574-71E55E3D-D220-40F7-8AFD-BBE1FB7C1A44 @default.
- Q65537574 P17 Q65537574-761C9021-671E-4A33-9412-DF2D7003C98A @default.
- Q65537574 P17 Q65537574-8FFE76F2-9F15-491E-B498-95F7CFFB6841 @default.
- Q65537574 P17 Q65537574-B1B1C2A8-CAAF-4E98-941D-02D707FD8E11 @default.
- Q65537574 P17 Q65537574-C484665B-AA7E-4EE6-96FB-589CAFCF7337 @default.
- Q65537574 P2899 Q65537574-1CEDA2F7-D2FC-4EFE-9FC7-9B1325945E16 @default.
- Q65537574 P3098 Q65537574-4906D051-A783-472A-AEC0-4FF1220380D2 @default.
- Q65537574 P31 Q65537574-4831506D-263F-4103-B670-3EE7485CE763 @default.
- Q65537574 P580 Q65537574-96386163-67E1-47BA-94B1-704D80C91607 @default.
- Q65537574 P582 Q65537574-C24855E7-C0E4-4DFB-9306-4EE3A9750203 @default.
- Q65537574 P6099 Q65537574-F42619F6-4B4A-4D83-B819-2E6D5E666CB9 @default.
- Q65537574 P8363 Q65537574-BFD61DD3-4E08-4061-8844-CEE9825DC3A1 @default.
- Q65537574 P1050 Q170990 @default.
- Q65537574 P1132 "+461" @default.
- Q65537574 P1476 "A Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Golimumab, a Fully Human Anti-TNFa Monoclonal Antibody, Administered Subcutaneously in Subjects With Active Rheumatoid Arthritis and Previously Treated With Biologic Anti- TNFa Agent(s)" @default.
- Q65537574 P17 Q145 @default.
- Q65537574 P17 Q16 @default.
- Q65537574 P17 Q183 @default.
- Q65537574 P17 Q29 @default.
- Q65537574 P17 Q30 @default.
- Q65537574 P17 Q33 @default.
- Q65537574 P17 Q40 @default.
- Q65537574 P17 Q408 @default.
- Q65537574 P17 Q55 @default.
- Q65537574 P17 Q664 @default.
- Q65537574 P2899 "+18" @default.
- Q65537574 P3098 "NCT00299546" @default.
- Q65537574 P31 Q30612 @default.
- Q65537574 P580 "2006-02-01T00:00:00Z" @default.
- Q65537574 P582 "2007-08-01T00:00:00Z" @default.
- Q65537574 P6099 Q42824827 @default.
- Q65537574 P8363 Q78089383 @default.